Back to search results

The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy

Abroad (travel likely)UnknownPHASE4

Conditions

Duchenne Muscular Dystrophy · Cardiomyopathies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Suzuka Hospial, Suzuka, Mie-ken, Japan

    Contact: Study coordinator (Takao Nishizawa, MD. PhD) · nishizta@med.nagoya-u.ac.jp · +81-52-744-2150
    Contact: Study coordinator (Fumihiko Yasuma, MD. PhD) · yasuma@suzuka.go.jp · +81-593-78-0337
    Fumihiko Yasuma, MD, PhD (Sub-investigator)
    Toshimitsu Mori, MD (Sub-investigator)
    Motoko Sakai, MD, PhD (Sub-investigator)
    Satoshi Kuru, MD, PhD (Sub-investigator)
    Seigo Kimura, MD (Sub-investigator)
    Takuya Tamura, MD (Sub-investigator)
    Kentaro Sahashi, MD (Sub-investigator)
    Rei Shibata, MD, PhD (Sub-investigator)
    Taiki Ohashi, MD (Sub-investigator)
Study leads

  • Takao Nishizawa, MD, PhD

    Principal Investigator

    Department of Cardiology, Nagoya University Graduate School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)